JPH0465838B2 - - Google Patents
Info
- Publication number
- JPH0465838B2 JPH0465838B2 JP17966083A JP17966083A JPH0465838B2 JP H0465838 B2 JPH0465838 B2 JP H0465838B2 JP 17966083 A JP17966083 A JP 17966083A JP 17966083 A JP17966083 A JP 17966083A JP H0465838 B2 JPH0465838 B2 JP H0465838B2
- Authority
- JP
- Japan
- Prior art keywords
- synthesis
- protecting group
- reactor
- absorbance
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003153 chemical reaction reagent Substances 0.000 claims description 40
- 125000006239 protecting group Chemical group 0.000 claims description 30
- 239000002773 nucleotide Substances 0.000 claims description 24
- 125000003729 nucleotide group Chemical group 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 238000002835 absorbance Methods 0.000 claims description 10
- 238000001668 nucleic acid synthesis Methods 0.000 claims description 9
- 230000000873 masking effect Effects 0.000 claims description 7
- 238000009833 condensation Methods 0.000 claims description 5
- 230000005494 condensation Effects 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 description 28
- 238000003786 synthesis reaction Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 20
- 239000007788 liquid Substances 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- 238000010790 dilution Methods 0.000 description 11
- 239000012895 dilution Substances 0.000 description 11
- 239000002699 waste material Substances 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229910001873 dinitrogen Inorganic materials 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000011481 absorbance measurement Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- -1 4-monomethoxytrityl group Chemical group 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229940113082 thymine Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 2
- SFYDWLYPIXHPML-UHFFFAOYSA-N 3-nitro-1-(2,4,6-trimethylphenyl)sulfonyl-1,2,4-triazole Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)N1N=C([N+]([O-])=O)N=C1 SFYDWLYPIXHPML-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 229920004459 Kel-F® PCTFE Polymers 0.000 description 1
- AJZZHFTYVKGGRN-UHFFFAOYSA-N P(=O)(=O)C1=[C-]N=NN1 Chemical compound P(=O)(=O)C1=[C-]N=NN1 AJZZHFTYVKGGRN-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- UUAGAQFQZIEFAH-UHFFFAOYSA-N chlorotrifluoroethylene Chemical compound FC(F)=C(F)Cl UUAGAQFQZIEFAH-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229940102001 zinc bromide Drugs 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Saccharide Compounds (AREA)
Description
【発明の詳細な説明】
(イ) 産業上の利用分野
この発明は、DNAやRNAなどの核酸合成装置
に関する。[Detailed Description of the Invention] (a) Industrial Application Field This invention relates to a device for synthesizing nucleic acids such as DNA and RNA.
(ロ) 従来技術
核酸の合成法として、いわゆるジエステル法、
トリエステル法、ホスフアイト法と改良発展がな
され、さらにこれらの方法を利用し、固形支持体
を用いる固形支持体法が各種の利点を有すること
から多用されるに至つている。そしてこれらの方
法によつて核酸合成を行う装置も各種提案されて
いる。(b) Prior art As a nucleic acid synthesis method, the so-called diester method,
Improvements and developments have been made to the triester method and the phosphite method, and the solid support method, which utilizes these methods and uses a solid support, has come to be widely used because it has various advantages. Various apparatuses for synthesizing nucleic acids using these methods have also been proposed.
いずれの装置も基本的には、反応器、保護基で
ブロツクされた複数種のヌクレオチド試薬を所定
の手順で前記反応器に供給可能なヌクレオチド試
薬供給手段、保護基脱離剤と合成用縮合剤とマス
キング剤とマスキング用縮合剤とを各々前記反応
器に供給可能な反応試薬供給手段および前記ヌク
レオチド試薬供給手段と前記反応試薬供給手段と
を制御して保護基離脱工程との合成縮合工程とマ
スキング縮合工程とを繰返して該酸合成を遂行す
る制御手段を具備してなつている。 Each device basically consists of a reactor, a nucleotide reagent supply means capable of supplying multiple types of nucleotide reagents blocked with protecting groups to the reactor in a predetermined procedure, a protecting group removing agent, and a condensing agent for synthesis. A reaction reagent supply means capable of supplying a masking agent and a masking condensation agent to the reactor, respectively, and a synthetic condensation step with a protecting group removal step and masking by controlling the nucleotide reagent supply means and the reaction reagent supply means. The apparatus is equipped with a control means for repeating the condensation step to accomplish the acid synthesis.
ところでヌクレオチド試薬は基本的に塩基の違
いによつて4種類あり、これらを用いる手順を正
しくしなければ所望の塩基シーケンスをもつ核酸
を合成することはできない。 By the way, there are basically four types of nucleotide reagents depending on their bases, and unless the procedure for using these reagents is correct, it is not possible to synthesize a nucleic acid with a desired base sequence.
しかし、従来の核酸合成装置では、ヌクレオチ
ド試薬が正しく所定の手順で用いられているか否
かをチエツクすることができなかつたので、たと
えばヌクレオチド試薬を装置に誤つてセツトする
ことによつてしばしば誤つた塩基シーケンスの核
酸を合成してしまうことがあつた。 However, in conventional nucleic acid synthesizers, it is not possible to check whether the nucleotide reagents are used correctly in a given procedure, so mistakes are often made, for example, by incorrectly setting the nucleotide reagents in the device. There was a case where a nucleic acid with a base sequence was synthesized.
(ハ) 発明の目的
この発明は、核酸合成の際にヌクレオチド試薬
が正しく所定の手順で用いらるれているか否かを
チエツクすることが可能な核酸合成装置を提供す
ることを目的とする。(c) Purpose of the Invention The purpose of the present invention is to provide a nucleic acid synthesis apparatus capable of checking whether nucleotide reagents are being used correctly in a predetermined procedure during nucleic acid synthesis.
(ニ) 発明の構成
この発明は、保護基でブロツクされた複数のヌ
クレオチド試薬を所定の手順で反応器に供給して
保護基離脱工程と縮合工程とマスキング工程とを
繰返し、核酸合成を行う装置において、反応器の
排液経路に保護基離脱工程での排液の吸光度を2
以上の異なる波長で測定しうる吸光測定手段を設
けると共にその吸光度測定手段の出力側にその出
力に基いて排液中に含まれる脱離した保護基の定
性および定量を行う定性・定量演算手段を設けて
なる核酸合成装置を提供する。(d) Structure of the Invention The present invention provides an apparatus for synthesizing nucleic acids by supplying a plurality of nucleotide reagents blocked with protecting groups to a reactor according to a predetermined procedure and repeating a protecting group removal step, a condensation step, and a masking step. In this case, the absorbance of the waste liquid from the protecting group removal step is set to 2 in the drain path of the reactor.
In addition to providing an absorbance measuring means capable of measuring at different wavelengths as mentioned above, a qualitative/quantitative calculation means is provided on the output side of the absorbance measuring means for qualitatively and quantitatively determining the eliminated protecting group contained in the waste liquid based on the output thereof. A nucleic acid synthesis device is provided.
異なる種類のヌクレオチド試薬ごとに異なる種
類の保護基を付けておき、脱離した保護基を定性
すれば、どのヌクレオチド試薬を用いたかを知る
ことができるで、それによりヌクレオチド試薬が
所定の手順で用いられているかを否かをチエツク
できる。 By attaching different types of protecting groups to different types of nucleotide reagents and qualitatively characterizing the removed protecting groups, it is possible to know which nucleotide reagent was used, thereby ensuring that the nucleotide reagents are not used in a given procedure. You can check whether it is set or not.
上記吸光度測定手段および上記定性・定量演算
手段を従来公知の核酸合成装置に付設すること
で、容易にこの発明の装置を達成できるものであ
る。 The apparatus of the present invention can be easily achieved by attaching the absorbance measurement means and the qualitative/quantitative calculation means to a conventionally known nucleic acid synthesis apparatus.
(ホ) 実施例
第1図に示す(1)は、この発明の一実施例であ
り、ホスホトリエステル法によるDNA微量自動
合成装置である。(E) Embodiment (1) shown in FIG. 1 is an embodiment of the present invention, which is an automatic DNA microsynthesis device using the phosphotriester method.
まず、合成部の構成について説明する。 First, the configuration of the synthesis section will be explained.
反応器2は内径8mm、高さ10mmの円筒状の本体
3の上方にすりばち状フランジ4を設けた容器で
ある。すりばち状フランジ4には、多数の試薬溶
液等供給用のノズルが挿着された栓5が装着され
ている。そこで、本体3の頭部開口が試薬溶液等
供給口6となる。本体3の内部下方にはガラスフ
イルタのごときフイルタ7が嵌着され、さらに底
部には排液口8が設けられている。フイルタ7
は、ポリスチレン、シリカビーズのごとき支持体
9を載置できる(透過させない)もので、試薬溶
液、溶媒、ガスを透過させるものでいる。フイル
タ7の上部空間が反応部10になり、約450μlの
容積の空間である。 The reactor 2 is a container having a cylindrical main body 3 with an inner diameter of 8 mm and a height of 10 mm, and a mortar-shaped flange 4 provided above. The dome-like flange 4 is fitted with a stopper 5 into which a number of nozzles for supplying reagent solutions and the like are inserted. Therefore, the head opening of the main body 3 becomes the reagent solution supply port 6. A filter 7 such as a glass filter is fitted inside the main body 3, and a drain port 8 is provided at the bottom. Filter 7
The support member 9, such as polystyrene or silica beads, can be placed thereon (not permeable), and is permeable to reagent solutions, solvents, and gases. The space above the filter 7 becomes the reaction section 10, which has a volume of about 450 μl.
試薬溶液は全部で8種類ある。 There are 8 types of reagent solutions in total.
11〜14は各種のヌクレオチド試薬溶液で、
それぞれ塩基にアデニン、シトシン、グアニン、
チミンを有している。アデニンを塩基にもつヌク
レオチド試薬溶液11の5′は水酸基は、4−モ
ノメトキシトリチル基(MMTr)を保護基とし
てブロツクされている。同様に、シトシンを塩基
にもつヌクレオチド試薬溶液12は4,4′−ジメ
トキシトリチル基(DMTr)でブロツクされて
おり、グアニンを塩基にもつヌクレオチド試薬溶
液13は4,4′,4″−トリメトキシトリエチル基
(TMTr)でブロツクされており、チミンを塩基
にもつヌクレオチド試薬溶液14はトリメチル基
(Tr)でブロツクされている。 11 to 14 are various nucleotide reagent solutions,
The bases are adenine, cytosine, and guanine, respectively.
Contains thymine. The 5' hydroxyl group of the nucleotide reagent solution 11 having adenine as a base is blocked using a 4-monomethoxytrityl group (MMTr) as a protecting group. Similarly, the nucleotide reagent solution 12 having cytosine as a base is blocked with 4,4'-dimethoxytrityl group (DMTr), and the nucleotide reagent solution 13 having guanine as a base is blocked with 4,4',4''-trimethoxytrityl group (DMTr). The nucleotide reagent solution 14 having thymine as a base is blocked with a trimethyl group (Tr).
15は縮合剤で、2−4−6−トリメチルベン
ゼンスルホニル−3−ニトロトリアゾリド
(MSNT)のピリジン溶液である。39は保護基
脱離剤で、イソプロパノールと塩化メチレンの混
合溶媒に臭化亜鉛を溶解した溶液である。40は
マスキング用試薬で、無水酢酸とピリジンの混合
液である。41はマスキング用縮合剤で、ジメチ
ルアミノピリジンのピリジン溶液である。 15 is a condensing agent, which is a pyridine solution of 2-4-6-trimethylbenzenesulfonyl-3-nitrotriazolide (MSNT). 39 is a protecting group removing agent, which is a solution of zinc bromide dissolved in a mixed solvent of isopropanol and methylene chloride. 40 is a masking reagent, which is a mixed solution of acetic anhydride and pyridine. 41 is a condensing agent for masking, which is a pyridine solution of dimethylaminopyridine.
シリンジポンプ21〜25は、それぞれ切換コ
ツク16〜20を介して上記試薬溶液11〜15
を吸収し、反応器2へ供給しうる。 The syringe pumps 21 to 25 are connected to the reagent solutions 11 to 15 through switching tips 16 to 20, respectively.
can be absorbed and fed to reactor 2.
シリンジポンプ21〜25のプラジヤはそれぞ
れプランジヤ駆動機構26〜30で駆動される。 The plungers of the syringe pumps 21-25 are driven by plunger drive mechanisms 26-30, respectively.
プランジヤ駆動機構26は、パルスモータ31
と、それにより回転されるネジ軸32と、そのネ
ジ軸33の回転により移動してプランジヤ21a
を上下させるナツト33とからなつており、パル
スモータ31はマイクロコンピユータのごとき制
御回路34でパルス制御されている。他のプラン
ジヤ駆動機構27〜30も同様の構造である。 The plunger drive mechanism 26 is driven by a pulse motor 31
and the screw shaft 32 rotated thereby, and the plunger 21a moved by the rotation of the screw shaft 33.
The pulse motor 31 is pulse-controlled by a control circuit 34 such as a microcomputer. The other plunger drive mechanisms 27 to 30 have similar structures.
36〜38は溶媒で、それぞれ乾燥用揮発性溶
媒のテトラヒドロフラン(THF)、洗浄用溶媒の
ピリジン、同じく洗浄用溶媒のイソプロパノール
と塩化メチレンの混合液である。これら溶媒36
〜38および前記試薬溶液39〜41は、窒素ガ
ス圧によつてそれぞれ弁42〜47を介して反応
器2に供給されうる。 Solvents 36 to 38 are tetrahydrofuran (THF) as a volatile drying solvent, pyridine as a cleaning solvent, and a mixture of isopropanol and methylene chloride, also as a cleaning solvent. 36 of these solvents
38 and the reagent solutions 39 to 41 can be supplied to the reactor 2 via valves 42 to 47, respectively, by nitrogen gas pressure.
弁48は、窒素ガスで反応器2内をブローする
ために、窒素ガスを直接反応器2を供給するもの
である。窒素ガスは塩化カルシウムのごとき乾燥
剤49で乾燥されている。 The valve 48 is for directly supplying nitrogen gas to the reactor 2 in order to blow the inside of the reactor 2 with nitrogen gas. The nitrogen gas is dried with a desiccant 49 such as calcium chloride.
制御回路34は、前述のようにプランシヤ制御
機構26〜30を制御する外に、切換コツク16
〜20、弁42〜48、排液弁50および排気弁
51の作動を制御する。また、操作卓35を介し
てオペレータと対話を行う。 In addition to controlling the planshaft control mechanisms 26 to 30 as described above, the control circuit 34 also controls the switching mechanism 16.
-20, controls the operation of valves 42-48, drain valve 50, and exhaust valve 51. The user also interacts with the operator via the console 35.
切換コツク52は、反応器2の排液流路53を
廃棄流路54もしくは測定流路55に切換接続す
るもので、制御回路34によつて作動を制御され
る。 The switching cock 52 switches and connects the drain flow path 53 of the reactor 2 to the waste flow path 54 or the measurement flow path 55, and its operation is controlled by the control circuit 34.
希釈容器56は内容量1200ml位の円筒状容器
で、頭部は前記測定流路55と接続されており、
底部は測定弁57を介して吸光度測定ユニツト6
8のフローセル69に接続されている。 The dilution container 56 is a cylindrical container with an internal capacity of about 1200 ml, and its head is connected to the measurement channel 55.
The bottom part is connected to the absorbance measuring unit 6 via the measuring valve 57.
8 flow cell 69.
希釈容器56の側壁には光学式レベルセンサ5
8が取り付けられ、そのレベルセンサの出力は制
御回路34に接続されている。 An optical level sensor 5 is installed on the side wall of the dilution container 56.
8 is attached, and the output of the level sensor is connected to the control circuit 34.
希釈容器56には、弁63を介して希釈および
洗浄のための液たとえば4%トリクロロ酢酸を含
む二塩化メチレン60を供給可能である。さらに
希釈容器56の頭部および底部から内部に、弁6
5,66を介して窒素ガスを供給可能である。こ
れらの弁63,65,66および排気弁67およ
び前記測定弁57は制御回路34にて作動を制御
される。 The dilution vessel 56 can be supplied with a dilution and washing liquid via a valve 63, for example methylene dichloride 60 containing 4% trichloroacetic acid. Further, a valve 6 is inserted into the dilution container 56 from the top and bottom.
Nitrogen gas can be supplied via 5 and 66. The operation of these valves 63, 65, 66, exhaust valve 67, and measurement valve 57 is controlled by a control circuit 34.
吸光度測定ユニツト68は、色色光源70から
出た光を干渉フイルタで単波長とし、フローセル
69を通して受光器78にて検知する。第2図に
示すように、干渉フイルタは72〜75の4種類
ある。干渉フイルタ72は波長500nm位の光を透
過し、干渉フイルタ73は波長480nm位の光を透
過し、干渉フイルタ74は波長440nm位の光透過
し、干渉フイルタ75は波長420nm位の光を透過
する。回転軸71aのまわりにホルダー71を回
転することでこれら干渉フイルタ72〜75のい
ずれか一つを選択して用いることができる。第1
図とは直角の方向から見た吸光度測定ユニツト6
8を第3図に示す。77はレフアレンス・セル、
79は受光器である。受光器78,79の出力は
制御回路34に接続されており、制御回路34は
受光器78,79の出力信号に基いて、脱離され
た保護基の定性と定量と収率の算出を行う。 The absorbance measurement unit 68 converts the light emitted from the colored light source 70 into a single wavelength using an interference filter, and detects the light with a light receiver 78 through a flow cell 69 . As shown in FIG. 2, there are four types of interference filters, 72 to 75. The interference filter 72 transmits light with a wavelength of approximately 500 nm, the interference filter 73 transmits light with a wavelength of approximately 480 nm, the interference filter 74 transmits light with a wavelength of approximately 440 nm, and the interference filter 75 transmits light with a wavelength of approximately 420 nm. . By rotating the holder 71 around the rotating shaft 71a, any one of these interference filters 72 to 75 can be selected and used. 1st
Absorbance measurement unit 6 viewed from a direction perpendicular to the figure.
8 is shown in FIG. 77 is reference cell,
79 is a light receiver. The outputs of the photodetectors 78 and 79 are connected to a control circuit 34, and the control circuit 34 qualitatively and quantitatively determines the removed protecting group and calculates the yield based on the output signals of the photodetectors 78 and 79. .
DNA合成に際しては、まず栓5をはずして反
応器2内に、DMA分子の末端部分のみを結合し
た支持体9を入れる。この量は、たとえば支持体
9がポリスチレン粉体の場合には10mg〜50mgが好
適である。なお、DNA分子の末端部分の5′水酸
基たとえばDMTrでブロツクされている。栓5
を元に戻した後、入れた支持体9の量などを操作
卓35を介して制御回路34に入力し、ついでス
タート指令を入力する。 For DNA synthesis, first, the stopper 5 is removed and a support 9 to which only the terminal portions of DMA molecules are bound is placed in the reactor 2. This amount is preferably 10 mg to 50 mg, for example, when the support 9 is a polystyrene powder. Note that the 5' hydroxyl group at the end of the DNA molecule is blocked with, for example, DMTr. Stopper 5
After returning the support body 9 to its original position, the amount of the support 9 put in is inputted to the control circuit 34 via the operation console 35, and then a start command is inputted.
すると制御回路34は、切換コツク16〜2
0、プランジヤ駆動回路26〜30、弁42〜4
8,50,51を適切に作動させて、第4図Aに
示す合成サイクルを実行し、操作卓35で入力さ
れた目的DNAを合成する。そして同時に、第2
図Bに示す定性・定量・収率測定を行う。 Then, the control circuit 34 switches between the switching switches 16 to 2.
0, plunger drive circuit 26-30, valve 42-4
8, 50, and 51 to execute the synthesis cycle shown in FIG. And at the same time, the second
Perform qualitative, quantitative, and yield measurements as shown in Figure B.
すなわち、脱保護基工程において反応器2から
排液を何回か排出する際、切換コツク52を測定
流路55側に切換えてそれを希釈容器56に分取
する。また、イソプロパノールと塩化メチレンの
混合液38で洗浄するときの排液も同様に希釈容
器56に分取する。こうして、脱離された保護基
を全て希釈容器56に集める。その後、制御回路
34は、切換コツク52を廃棄流路54側に戻
し、合成サイクルを続行するのと並行して次のよ
うに動作する。 That is, when discharging the waste liquid from the reactor 2 several times in the deprotection step, the switching pot 52 is switched to the measurement flow path 55 side and the liquid is collected into the dilution container 56. Further, the waste liquid from washing with the mixed solution 38 of isopropanol and methylene chloride is similarly collected into the dilution container 56. In this way, all of the removed protecting groups are collected in the dilution container 56. Thereafter, the control circuit 34 operates as follows in parallel with returning the switching pot 52 to the waste channel 54 and continuing the synthesis cycle.
まず弁63を作動して希釈液60を注入し、液
面がレベルセンサ58の位置となるようにする。
これによつて、測定対象である前記排液は適切な
一定濃度に希釈される。次に弁66を作動して窒
素ガスでバブリングし、希釈容器56内に撹拌
し、弁57,65を作動し、フローセル69を通
じて排出する。このときフイルタ72,73,7
4,75のそれぞれを用いて異なる波長で吸光度
測定を行い、その後、希釈液60で洗浄する。 First, the valve 63 is operated to inject the diluent 60 so that the liquid level is at the level sensor 58.
As a result, the waste liquid to be measured is diluted to an appropriate constant concentration. Next, valve 66 is activated to bubble nitrogen gas into the dilution container 56, and valves 57 and 65 are activated to discharge nitrogen gas through flow cell 69. At this time, filters 72, 73, 7
Absorbance is measured at different wavelengths using each of Nos. 4 and 75, and then washed with diluent 60.
第5図イ,ロ,ハ,ニは、それぞれMMTr、
DMTr、TMTr、Trの吸光度スペクトルの図で
ある。図より容易に理解されるように、420nm、
440nm、480nmおよび500nmにおける吸光度を得
れば、それらの相対パターンから、保護基が
MMTrか、DMTrか、TMTrか、Trかを同定す
ることができる。脱離された保護基をかくして定
性した後、それが予め設定していた順番の保護基
であるか否かをチエツクする。そしてもし異なつ
た保護基であれば、それは所定の手順のヌクレオ
チド試薬が用いられなかつたことを意味している
から、合成サイクルを停止し、操作卓35におい
てアラームランプを点灯するなどしてオペレータ
に警報を発する。一方、定性した保護基が予め設
定していた順番の保護基であれば、ヌクレオチド
試薬が所定の手順で用いられていることを意味し
ているから、次に定量を行う。 Figure 5 A, B, C, and D are MMTr, respectively.
It is a diagram of absorbance spectra of DMTr, TMTr, and Tr. As can be easily understood from the figure, 420nm,
By obtaining the absorbance at 440nm, 480nm and 500nm, their relative patterns indicate that the protecting group is
It is possible to identify whether it is MMTr, DMTr, TMTr, or Tr. After the removed protecting groups are thus qualitatively determined, it is checked whether the removed protecting groups are in the predetermined order. If it is a different protecting group, it means that the nucleotide reagent for the prescribed procedure was not used, so the synthesis cycle is stopped and the operator is notified by lighting an alarm lamp on the console 35, etc. Issue an alarm. On the other hand, if the qualitatively determined protecting groups are in a predetermined order, this means that the nucleotide reagent is used in a predetermined procedure, and therefore quantification is performed next.
定量は、定性によつて保護基の種類に分つてお
りかつ排液の希釈度も適切な一定濃度であるか
ら、予め設定されていた校正値と比較することで
容易に行いうる。定量の後、収率の演算を行う。 Since the type of protecting group is qualitatively classified and the dilution of the waste liquid is an appropriate constant concentration, quantitative determination can be easily performed by comparing with preset calibration values. After quantitative determination, calculation of yield is performed.
収率の演算は、その合成サイクルにおける定量
値を、記憶しておいた前回の合成サイクルにおけ
る定量値で徐して100を乗じることによつて行う。
得られた収率は、前回の合成サイクルの収率であ
る。つまり第1回目の合成サイクルの収率は、第
2回目の合成サイクルの途中で得られることにな
る。その収率は操作卓35において表示される。 The calculation of yield is performed by dividing the quantitative value in the synthesis cycle by the memorized quantitative value in the previous synthesis cycle and multiplying by 100.
The yield obtained is that of the previous synthesis cycle. In other words, the yield of the first synthesis cycle is obtained in the middle of the second synthesis cycle. The yield is displayed on the console 35.
制御回路34は、上記のように或る合成サイク
ルの収率を演算すると共に、それまでの合成サイ
クルの収率のすべて乗じて全体の収率を演算し、
それを操作卓35において表示する。 The control circuit 34 calculates the yield of a certain synthesis cycle as described above, and calculates the overall yield by multiplying all the yields of the previous synthesis cycles.
It is displayed on the console 35.
さらに制御回路34は、或る合成サイクルの収
率が所定値(たとえば80%)以上であるか否かの
判断と全体の収率が所定値(たとえば30%)以上
であるか否かの判断とを行い、いずれか一方でも
所定値以上でない場合には並行して実行している
合成サイクルを停止し、操作卓35においてアラ
ームランムを点灯するなどしてオペレータに警報
を発する。 Furthermore, the control circuit 34 determines whether the yield of a certain synthesis cycle is equal to or higher than a predetermined value (for example, 80%) and determines whether the overall yield is equal to or higher than a predetermined value (for example, 30%). If either one of them is not equal to or greater than a predetermined value, the synthesis cycle that is being executed in parallel is stopped, and an alarm lamp is lit on the console 35 to issue a warning to the operator.
合成部の変形例として、反応器2をロート状に
したもの、樽状にしたもの、また反応部の容積を
80μ〜800μの間で変化したものが挙げられ
る。また固体支持体としてkel−F・gスチレン、
シリカゲル、ポリアクリルモルホリドなどを用い
たものが挙げられる。これらの支持体は粒径30〜
300ミクロン程度のものが好ましい。 As a modification of the synthesis section, reactor 2 may be made into a funnel shape, a barrel shape, or the volume of the reaction section may be reduced.
Examples include those varying between 80μ and 800μ. In addition, kel-F・g styrene was used as a solid support.
Examples include those using silica gel, polyacrylic morpholide, etc. These supports have a particle size of 30~
A thickness of about 300 microns is preferable.
脱保護基定量の変形例としては、脱保護基工程
で何回か排出される排液を集めてから希釈してい
るが、排出されるごとに定量し、これらを積算し
て脱離された保護基の総量を求めるようにしても
よい。 A variation of the method for quantifying deprotecting groups is to collect the waste fluid discharged several times during the deprotection process and then dilute it. The total amount of protecting groups may also be determined.
吸光度測定ユニツト68の変形例としては、定
性すべき保護基の種類に応じて干渉フイルタの数
(すなわち測定波長の数)を増減したものが挙げ
られる。さらにグレーテイングやプリズムを用い
た分光光度計でスペクトルを測定するものが挙げ
られる。 A modification of the absorbance measurement unit 68 includes one in which the number of interference filters (ie, the number of measurement wavelengths) is increased or decreased depending on the type of protecting group to be qualitatively determined. Further examples include those that measure spectra with spectrophotometers that use gratings or prisms.
保護基は、上記実施例で挙げた以外の低級アル
コキシ基で任意に置換されたトリチル基を用いて
もよい。 As the protecting group, a trityl group optionally substituted with a lower alkoxy group other than those listed in the above examples may be used.
また希釈液に代えて希釈発色液たとえばエタノ
ールと過塩素酸の混合液を加えるようにしてもよ
い。 Further, instead of the diluting liquid, a diluted coloring liquid such as a mixed liquid of ethanol and perchloric acid may be added.
他の実施例としては、ホスホモノトリアゾリド
法やホスフアイト法、あるいはジエステル法によ
るDNA等合成装置にこの発明を適用したものが
挙げられる。また複数の合成部に対して1つの脱
保護基定量・収率演算・自動停止制御部を対応さ
せたものが挙げられる。この場合、収率の高い合
成部では合成動作が続行され、収率の低い合成部
では合成部が停止されるようになる。 Other examples include those in which the present invention is applied to a DNA synthesis apparatus using the phosphomonotriazolide method, the phosphite method, or the diester method. Another example is one in which one deprotecting group quantitative determination/yield calculation/automatic stop control section is associated with a plurality of synthesis sections. In this case, the synthesis operation is continued in the synthesis section with a high yield, and the synthesis operation is stopped in the synthesis section with a low yield.
なお収率の低下により停止しても、オペレータ
の指示によつて再び合成動作を続行しうるように
するのが好ましい。 Note that even if the synthesis operation is stopped due to a decrease in yield, it is preferable to continue the synthesis operation again according to instructions from the operator.
上記の実施例のDNA合成装置1によれば、反
応器2の反応部10を小型化すると共に、フイル
タ7の上に支持体9を載置し、上方から試薬溶液
11〜15を供給し、底部から排液するように反
応器2を構成している。そこで排液弁50を閉じ
たまま試薬溶液を上方から供給すれば、その試薬
溶液は支持体9に含まれてこれを膨潤すると共に
フイルタ7より上の反応部10内にとどまつて下
方へ落ちない。従つて、供給した全ての試薬溶液
が反応に参加し、デツトスペースに溜まるものが
無くなる。この結果、供給量は最低量(支持体体
積の5〜7倍位)で充分になり、また反応を促進
するために反応器を振侭するなどの混合・接触操
作も無用になつている。また、新たなヌクレオチ
ドを連結する反応の前に反応器2内をTHF36
で洗浄乾燥すると共に乾燥ガスでブローして短時
間で反応器2内を完全乾燥できるように構成され
ており、この結果、縮合反応を阻害する水分を完
全に除去できるので反応効率が下がらず、余分な
試薬を必要としない。さらに、合成中に反応収率
を容易に知ることができて非常に便利である。な
んとなれば、合成が適正に行われているか否かの
チエツクを極めて容易に行えるからである。ま
た、収率が所定レベルより落ちたときに自動的に
合成の動作を停止するから、試薬と時間の無駄が
省かれると共に無人運転も可能となり、実用的で
ある。 According to the DNA synthesis apparatus 1 of the above embodiment, the reaction section 10 of the reactor 2 is miniaturized, the support 9 is placed on the filter 7, and the reagent solutions 11 to 15 are supplied from above, The reactor 2 is configured so that liquid is drained from the bottom. Therefore, if a reagent solution is supplied from above with the drain valve 50 closed, the reagent solution will be contained in the support 9 and swell it, and will remain in the reaction section 10 above the filter 7 and will not fall downward. . Therefore, all the supplied reagent solutions participate in the reaction, and nothing accumulates in the dead space. As a result, the minimum amount of feed (approximately 5 to 7 times the volume of the support) is sufficient, and mixing and contacting operations such as shaking the reactor to promote the reaction are no longer necessary. In addition, before the reaction to link new nucleotides, the inside of reactor 2 was heated with THF36.
The reactor 2 is configured to be washed and dried with water and blown with dry gas to completely dry the inside of the reactor 2 in a short time.As a result, water that inhibits the condensation reaction can be completely removed, so the reaction efficiency does not decrease. No extra reagents required. Furthermore, it is very convenient to easily know the reaction yield during synthesis. This is because it is extremely easy to check whether the synthesis is being performed properly. Furthermore, since the synthesis operation is automatically stopped when the yield falls below a predetermined level, waste of reagents and time is avoided, and unattended operation is also possible, which is practical.
(ヘ) 発明の効果
この発明の核酸合成装置によれば、保護基離脱
工程で離脱した保護基の定性を行うことができ
る。そこでたとえば異種のヌクレオチド試薬ごと
に保護基の種類を変えておけば、保護基を定性す
ることから逆に合成に用いられたヌクレオチド試
薬の種類を推定でき、所定の手順でヌクレオチド
試薬が用いられているか否かを確認することがで
きて、装置の信頼性が向上する。(F) Effects of the Invention According to the nucleic acid synthesis apparatus of the present invention, it is possible to qualitatively characterize the protecting group removed in the protecting group removal step. Therefore, for example, if the type of protecting group is changed for each different type of nucleotide reagent, the type of nucleotide reagent used in the synthesis can be estimated by qualitatively characterizing the protecting group, and the nucleotide reagent can be used in a predetermined procedure. The reliability of the device is improved because it can be confirmed whether the device is present or not.
第1図はこの発明の核酸合成装置の一実施例で
あるDNA微量合成装置の構成説明図、第2図は
第1図に示す装置の干渉フイルタ部分の構成説明
図、第3図は第1図に示す装置の吸光度測定ユニ
ツトの構成説明図、第4図は第1図に示す装置の
動作のフローチヤート、第5図イ〜ニはそれぞれ
保護基であるMMTr、DMTr、TMTrおよびTr
の吸光度のスペクトル図である。
1……DNA微量自動合成装置、2……反応器、
11〜14……ヌクレオチド試薬溶液、15,3
9〜41……試薬溶液、34……制御回路、35
……操作卓、52……切換コツク、53……排液
流路、55……測定流路、56……希釈容器、5
8……レベルセンサ、60……希釈液、68……
吸光度測定ユニツト、69……フローセル、7
2,73,74,75……干渉フイルタ、77…
…レフアレンスセル、78,79……受光器。
FIG. 1 is an explanatory diagram of the configuration of a micro-DNA synthesis device which is an embodiment of the nucleic acid synthesis device of the present invention, FIG. 2 is an explanatory diagram of the configuration of the interference filter portion of the device shown in FIG. 1, and FIG. 4 is a flowchart of the operation of the device shown in FIG. 1, and FIG.
It is a spectrum diagram of the absorbance of. 1...DNA micro-automatic synthesizer, 2...Reactor,
11-14... Nucleotide reagent solution, 15,3
9-41... Reagent solution, 34... Control circuit, 35
...Operation console, 52...Switching knob, 53...Drainage channel, 55...Measurement channel, 56...Dilution container, 5
8... Level sensor, 60... Diluent, 68...
Absorbance measurement unit, 69...flow cell, 7
2, 73, 74, 75...interference filter, 77...
...Reference cell, 78, 79... Light receiver.
Claims (1)
試薬を所定の手順で反応器に供給して保護基離脱
工程と縮合工程とマスキング工程とを繰返し、核
酸合成を行う装置において、 反応器の排液経路に保護基離脱工程での排液の
吸光度を2以上の異なる波長で測定しうる吸光度
測定手段を設けると共にその吸光度測定手段の出
力側にその出力に基いて排液中に含まれる脱離し
た保護基の定性および定量を行う定性・定量演算
手段を設けてなることを特徴とする核酸合成装
置。[Scope of Claims] 1. In an apparatus that performs nucleic acid synthesis by supplying a plurality of nucleotide reagents blocked with protecting groups to a reactor according to a predetermined procedure and repeating a protecting group removal step, a condensation step, and a masking step, a reaction is performed. An absorbance measuring means capable of measuring the absorbance of the effluent in the protecting group removal step at two or more different wavelengths is provided in the drainage path of the device, and the output side of the absorbance measuring means determines the amount of water contained in the effluent based on the output. 1. A nucleic acid synthesis apparatus comprising qualitative and quantitative calculation means for qualitatively and quantitatively determining the removed protecting group.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17966083A JPS6069095A (en) | 1983-09-27 | 1983-09-27 | Apparatus for synthesizing nucleic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP17966083A JPS6069095A (en) | 1983-09-27 | 1983-09-27 | Apparatus for synthesizing nucleic acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6069095A JPS6069095A (en) | 1985-04-19 |
| JPH0465838B2 true JPH0465838B2 (en) | 1992-10-21 |
Family
ID=16069649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP17966083A Granted JPS6069095A (en) | 1983-09-27 | 1983-09-27 | Apparatus for synthesizing nucleic acid |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6069095A (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6072898A (en) * | 1983-09-29 | 1985-04-24 | Shimadzu Corp | Apparatus for synthesizing nucleic acid |
| EP0649341B1 (en) * | 1992-07-06 | 1996-09-04 | Beckman Instruments, Inc. | On-line process flow and reaction monitor |
-
1983
- 1983-09-27 JP JP17966083A patent/JPS6069095A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6069095A (en) | 1985-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2118189A (en) | An automatic synthesizer for DNA | |
| US4744037A (en) | Polynucleotide synthesizing apparatus | |
| JPH03189562A (en) | Automatic immunoassay apparatus/method and tray for the apparatus | |
| EP0256684A2 (en) | Method and apparatus for measuring dissolved organic carbon in water | |
| CN211877777U (en) | Free calcium oxide tester | |
| JP2007525185A (en) | Equipment for automated synthesis of polynucleotides | |
| CN101942385B (en) | Full-automatic hybridization oven and implementation method and application thereof | |
| JPH0465838B2 (en) | ||
| EP0299419B1 (en) | Automatic measurement method of glycohemoglobin | |
| US6242262B1 (en) | Method and apparatus for screening catalyst libraries | |
| JPH0573758B2 (en) | ||
| Templeton et al. | Comparative study of a new fluorometric assay mestranol ether in tablets with glc and colorimetric assays | |
| CN223272389U (en) | A spectrophotometric detection device for activated carbon | |
| US4914036A (en) | Method and apparatus for simultaneously analyzing vanillylmandelic acid, homovanillic acid and creatinine | |
| JPS6311360B2 (en) | ||
| CN118817946B (en) | Determination of slurry components and oxidation rate in ammonia desulfurization process | |
| JPS623660A (en) | Precipitation reagent and fluorescent polarizing immunoassay using said reagent | |
| RU2232985C1 (en) | Method for determination of psoralene | |
| JPH05284999A (en) | Polynucleotide detection method | |
| CN118549564B (en) | One-step determination method for perfluoro/polyfluoroalkyl compound in serum | |
| JPS6241676B2 (en) | ||
| JP3911821B2 (en) | Ion concentration measuring device | |
| CA1052125A (en) | Photometric liquid analysers | |
| CS216612B1 (en) | Valve for taking reppresentative samples of reaction mixtures | |
| JP3146639B2 (en) | Automatic sample introduction device for flame atomic absorption spectrophotometer |